As of September 8, Novozymes has purchased an accumulated 5,454,871 shares with
a transaction value of DKK 1,562.9 million under the stock buyback program
Novozymes announced in Company announcement No. 4, 2017 and initiated January
25, 2017. 

Read the full announcement in PDF